Joanne Berghout

Joanne Berghout

Auto-generated profile, based on publicly available information

Joanne Berghout

University of Arizona

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2016 in Nature
Verified
Journal Article
Open access
PDF file
ECExome Aggregation Consortium
Exome Aggregation Consortium
MLMonkol Lek
Monkol Lek
KKKonrad J. Karczewski
Konrad J. Karczewski
EMEric Vallabh Minikel
Eric Vallabh Minikel
KSKaitlin E. Samocha
Kaitlin E. Samocha
DMDaniel G. MacArthur
Daniel G. MacArthur
Large-scale reference data sets of human genetic variation are critical for the medical and functional interpretation of DNA sequence changes. Here we describe the aggregation and analysis of high-quality exome (protein-coding region) DNA sequence data for 60,706 individuals of diverse ancestries generated as part of the Exome Aggregation Consortium (ExAC). This catalogue of human genetic diversity contains an average of one variant every eight bases of the exome, and provides direct evidence for the presence of widespread mutational recurrence. We have used this catalogue to calculate objective metrics of pathogenicity for sequence variants, and to identify genes subject to strong selection against various classes of mutation; identifying 3,230 genes with near-complete depletion of predicted protein-truncating variants, with 72% of these genes having no currently established human disease phenotype. Finally, we demonstrate that these data can be used for the efficient filtering of candidate disease-causing variants, and for the discovery of human ‘knockout’ variants in protein-coding genes.

5 April 2007 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
ZKZoha Kibar
Zoha Kibar
ETElena Torban
Elena Torban
JMJonathan R. McDearmid
Jonathan R. McDearmid
ARAnnie Reynolds
Annie Reynolds
JBJoanne Berghout
Joanne Berghout
PGPhilippe Gros
Philippe Gros
Neural-tube defects such as anencephaly and spina bifida constitute a group of common congenital malformations caused by complex genetic and environmental factors. We have identified three mutations in the VANGL1 gene in patients with familial types (V239I and R274Q) and a sporadic type (M328T) of the disease, including a spontaneous mutation (V239I) appearing in a familial setting. In a protein–protein interaction assay V239I abolished interaction of VANGL1 protein with its binding partners, disheveled-1, -2, and -3. These findings implicate VANGL1 as a risk factor in human neural-tube defects.

4 September 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YIYoussef Idaghdour
Youssef Idaghdour
JQJacklyn Quinlan
Jacklyn Quinlan
JGJean-Philippe Goulet
Jean-Philippe Goulet
JBJoanne Berghout
Joanne Berghout
EGElias Gbeha
Elias Gbeha
PAPhilip Awadalla
Philip Awadalla
The host mechanisms responsible for protection against malaria remain poorly understood, with only a few protective genetic effects mapped in humans. Here, we characterize a host-specific genome-wide signature in whole-blood transcriptomes of Plasmodium falciparum -infected West African children and report a demonstration of genotype-by-infection interactions in vivo. Several associations involve transcripts sensitive to infection and implicate complement system, antigen processing and presentation, and T-cell activation (i.e., SLC39A8 , C3AR1 , FCGR3B , RAD21 , RETN , LRRC25 , SLC3A2 , and TAPBP ), including one association that validated a genome-wide association candidate gene ( SCO1 ), implicating binding variation within a noncoding regulatory element. Gene expression profiles in mice infected with Plasmodium chabaudi revealed and validated similar responses and highlighted specific pathways and genes that are likely important responders in both hosts. These results suggest that host variation and its interplay with infection affect children’s ability to cope with infection and suggest a polygenic model mounted at the transcriptional level for susceptibility.

21 April 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SPSamir N. Patel
Samir N. Patel
JBJoanne Berghout
Joanne Berghout
FLFiona E. Lovegrove
Fiona E. Lovegrove
KAKodjo Ayi
Kodjo Ayi
ACAndrea L Conroy
Andrea L Conroy
KKKevin C. Kain
Kevin C. Kain
Experimental infection of mice with Plasmodium berghei ANKA (PbA) provides a powerful model to define genetic determinants that regulate the development of cerebral malaria (CM). Based on the hypothesis that excessive activation of the complement system may confer susceptibility to CM, we investigated the role of C5/C5a in the development of CM. We show a spectrum of susceptibility to PbA in a panel of inbred mice; all CM-susceptible mice examined were found to be C5 sufficient, whereas all C5-deficient strains were resistant to CM. Transfer of the C5-defective allele from an A/J (CM resistant) onto a C57BL/6 (CM-susceptible) genetic background in a congenic strain conferred increased resistance to CM; conversely, transfer of the C5-sufficient allele from the C57BL/6 onto the A/J background recapitulated the CM-susceptible phenotype. The role of C5 was further explored in B10.D2 mice, which are identical for all loci other than C5. C5-deficient B10.D2 mice were protected from CM, whereas C5-sufficient B10.D2 mice were susceptible. Antibody blockade of C5a or C5a receptor (C5aR) rescued susceptible mice from CM. In vitro studies showed that C5a-potentiated cytokine secretion induced by the malaria product P. falciparum glycosylphosphatidylinositol and C5aR blockade abrogated these amplified responses. These data provide evidence implicating C5/C5a in the pathogenesis of CM.

10 October 2016 in Nature Immunology
Verified
Journal Article
Closed access
STSabrina Torre
Sabrina Torre
MPMaria J Polyak
Maria J Polyak
DLDavid Langlais
David Langlais
NFNassima Fodil
Nassima Fodil
JKJames M Kennedy
James M Kennedy
PGPhilippe Gros
Philippe Gros

25 October 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CSConstance M. Smith
Constance M. Smith
JFJacqueline H. Finger
Jacqueline H. Finger
THTerry F. Hayamizu
Terry F. Hayamizu
IMIngeborg J. McCright
Ingeborg J. McCright
JXJingxia Xu
Jingxia Xu
MRMartin Ringwald
Martin Ringwald
The Gene Expression Database (GXD; http://www.informatics.jax.org/expression.shtml) is an extensive and well-curated community resource of mouse developmental expression information. GXD collects different types of expression data from studies of wild-type and mutant mice, covering all developmental stages and including data from RNA in situ hybridization, immunohistochemistry, RT-PCR, northern blot and western blot experiments. The data are acquired from the scientific literature and from researchers, including groups doing large-scale expression studies. Integration with the other data in Mouse Genome Informatics (MGI) and interconnections with other databases places GXD’s gene expression information in the larger biological and biomedical context. Since the last report, the utility of GXD has been greatly enhanced by the addition of new data and by the implementation of more powerful and versatile search and display features. Web interface enhancements include the capability to search for expression data for genes associated with specific phenotypes and/or human diseases; new, more interactive data summaries; easy downloading of data; direct searches of expression images via associated metadata; and new displays that combine image data and their associated annotations. At present, GXD includes >1.4 million expression results and 250 000 images that are accessible to our search tools.